# Cardiovascular and Endothelial Markers During OGTT Before and at Six and Twelve Months Post-treatment in Women With PCOS

> **NCT06889454** · — · RECRUITING · sponsor: **Attikon Hospital** · enrollment: 120 (estimated)

## Conditions studied

- PCOS
- Hyperinsulinism
- Hyperandrogenism
- Metabolic Syndrome

## Interventions

- **DRUG:** GLP-1 receptor agonist
- **DRUG:** Oral contraceptive
- **DRUG:** Metformin
- **OTHER:** Lifestyle modification

## Key facts

- **NCT ID:** NCT06889454
- **Lead sponsor:** Attikon Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-02-01
- **Primary completion:** 2025-02-01
- **Final completion:** 2026-02-01
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2025-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06889454

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06889454, "Cardiovascular and Endothelial Markers During OGTT Before and at Six and Twelve Months Post-treatment in Women With PCOS". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06889454. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*